Andere talen SOCL CAPI

Aandelen

DNAC

KYG8253W1096

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 05-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,25 ^USD	-3,43%		-8,54%	-77,13%

2022	Sociaal Kapitaal Suvretta Holdings Corp. III maakt winst bekend voor het tweede kwartaal en de zes maanden eindigend op 30 juni 2022	CI
2022	ProKidney voltooit SPAC-fusie met Sociaal Kapitaal Suvretta Holdings; aandelen beginnen met Nasdaq-handel	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Social Capital Suvretta Holdings Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12-08-22
SOCL CAPI : Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K	15-07-22
SOCL CAPI : Statement of Changes in Beneficial Ownership (Form 4)	14-07-22
SOCL CAPI : Statement of Changes in Beneficial Ownership (Form 4)	14-07-22
SOCL CAPI : Statement of Changes in Beneficial Ownership (Form 4)	14-07-22
SOCL CAPI : Statement of Changes in Beneficial Ownership (Form 4)	14-07-22
SOCL CAPI : Statement of Changes in Beneficial Ownership (Form 4)	14-07-22
SOCL CAPI : Statement of Changes in Beneficial Ownership (Form 4)	14-07-22
SOCL CAPI : Statement of Changes in Beneficial Ownership (Form 4)	14-07-22
SOCL CAPI : Statement of Changes in Beneficial Ownership (Form 4)	14-07-22
SOCL CAPI : Statement of Changes in Beneficial Ownership (Form 4)	14-07-22
SOCL CAPI : Statement of Changes in Beneficial Ownership (Form 4)	14-07-22
SOCL CAPI : Statement of Changes in Beneficial Ownership (Form 4)	13-07-22
SOCL CAPI : Statement of Changes in Beneficial Ownership (Form 4)	13-07-22
ProKidney Completes SPAC Merger With Social Capital Suvretta Holdings; Shares to Start Nasdaq Trading	12-07-22
Social Capital Suvretta III : Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III - Form 8-K	12-07-22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III	12-07-22
Social Capital Suvretta Holdings Corp. III(NasdaqCM:DNAC) dropped from NASDAQ Composite Index	12-07-22
Social Capital Suvretta III : Announces Reconvened Extraordinary General Meeting of Shareholders - Form 8-K	11-07-22
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	11-07-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen SOCL CAPI

Aandelen

DNAC

KYG8253W1096

Andere talen

Filters